After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
For the past few days, there has been a steady increase in the cases of corona in the country. In
The man who killed Paul Pelosi, the husband of US Parliament Speaker Nancy Pelosi, has been ident
Electronic machines were sent to the polling stations at 7 am tomorrow
Voting begins at 7 a.m. tomorrow in 1,374 wards in the metropolitan area, 3,843 wards in the muni
Concerned about rising inflation, the Reserve Bank of India has increased the repo rate by 0.50%.
Actor Pankaj Tripathi is shooting for the next part of 'Fukrey' in Delhi. However, he took time o
Palm Oil: Palm oil prices may fall by 20 percent by September, expected to go up to $ 673 per ton
The price of palm oil, the world's most consumed oil, is expected to fall sharply. It is believed
The countdown to the Union Budget 2026-27 has begun. As always, the central government is likely
The seven-day Kalki Mahotsav concluded on Sunday. During the closing ceremony, Jagadguru Rambhadr
On the notice of ED, Sanjay Raut said - come arrest me, it was anticipated earlier
Shiv Sena MP Sanjay Raut termed the summons issued to him by the Enforcement Directorate (ED) in
The Indian team won the T20 World Cup 2026 by defeating New Zealand by 96 runs in the final playe
